Global Medical REIT Inc.(GMRE)Earnings, Financials & Key Ratios
GMRE•NYSE•REIT / Real Estate
115.3× P/E·Price updated May 28, 2026
AboutGlobal Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.Show more
- Revenue$148M+7.1%
- FFO$46M-26.8%
- FFO/Share3.43-85.6%
- FFO Payout113.89%+19.3%
- FFO per Share3.43-85.6%
- NOI Margin100%+26.8%
- FFO Margin30.99%-31.6%
- ROE-2.23%-295.4%
- ROA-0.97%-284.5%
GMRE Key Insights
Global Medical REIT Inc. (GMRE) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High NOI margin of 100.0%
- ✓Trading at only 0.2x book value
✗Weaknesses
- ✗Weak 3Y average ROE of 0.7%
- ✗Profits declining 44.5% over 5 years
- ✗Weak Piotroski F-Score: 3/9
- ✗FFO declining 23.9% TTM
- ✗Dividend exceeds FFO - may not be sustainable
- ✗Shares diluted 100.0% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when GMRE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GMRE Price & Volume
Global Medical REIT Inc. (GMRE) stock price & volume — 10-year historical chart
Loading chart...
GMRE Growth Metrics
Global Medical REIT Inc. (GMRE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years53.34%
5 Years9.65%
3 Years2.61%
TTM7.08%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-282.66%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-6.38%
Return on Capital
10 Years4.59%
5 Years5.08%
3 Years5.41%
Last Year-
GMRE Recent Earnings
Global Medical REIT Inc. (GMRE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 8/12 qtrs (67%)
Q4 2025Latest
Nov 4, 2025Metric
Actual
Est
EPS
$1.12+6.7%
$1.05
Rev
$41M+8.3%
$37M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$1.15+0.0%
$1.15
Rev
$41M+14.7%
$36M
Q2 2025
May 7, 2025Metric
Actual
Est
EPS
$0.22+0.0%
$0.22
Rev
$35M-2.4%
$35M
Q1 2025
Feb 27, 2025Metric
Actual
Est
EPS
$0.22+2100.0%
$0.01
Rev
$35M+0.2%
$35M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2025Latest | Nov 4, 2025 | $1.12vs $1.05+6.7% | $41Mvs $37M+8.3% |
| Q3 2025 | Aug 5, 2025 | $1.15vs $1.15+0.0% | $41Mvs $36M+14.7% |
| Q2 2025 | May 7, 2025 | $0.22vs $0.22+0.0% | $35Mvs $35M-2.4% |
| Q1 2025 | Feb 27, 2025 | $0.22vs $0.01+2100.0% | $35Mvs $35M+0.2% |
Based on last 12 quarters of dataView full earnings history →
GMRE Peer Comparison
Global Medical REIT Inc. (GMRE) competitors in Outpatient medical offices and clinics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CHCT | 498.01M | 17.43 | 225.19 | 4.67% | 4.95% | 1.41% | 1.25 | |
 NXRT | 684.45M | 26.97 | -21.40 | -3.24% | -12.67% | -10.13% | 5.18 | |
 PLYM | 979.23M | 21.98 | 7.11 | -0.75% | 48.46% | 15.86% | 1.10 | |
 HR | 6.9B | 19.79 | -27.87 | -6.92% | -17.51% | -4.28% | 0.89 | |
 DOC | 13.6B | 19.56 | 195.60 | 4.52% | 7.73% | 2.6% | 1.26 | |
 MPW | 3.37B | 5.65 | -17.12 | -2.36% | -20.44% | -4.21% | 0.03 | |
 OHI | 13.26B | 44.53 | 22.95 | 13.95% | 51.02% | 11.85% | 0.78 | |
 SBRA | 4.57B | 18.12 | 28.31 | 10.15% | 19.21% | 5.6% | 0.90 |
Compare GMRE vs Peers
Global Medical REIT Inc. (GMRE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GMRE Income Statement
Global Medical REIT Inc. (GMRE) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 30.22M | 53.19M | 70.73M | 93.52M | 115.8M | 137.17M | 140.93M | 138.41M | 148.21M |
Revenue Growth % | 274.07% | 76% | 32.96% | 32.23% | 23.83% | 18.45% | 2.75% | -1.79% | 7.08% |
Property Operating Expenses | 1.86M | 3.72M | 6.54M | 10.87M | 15.49M | 25.19M | 28.08M | 29.25M | 0 |
Net Operating Income (NOI) | 28.36M▲ 0% | 49.47M▲ 74.4% | 64.19M▲ 29.7% | 82.65M▲ 28.8% | 100.32M▲ 21.4% | 111.98M▲ 11.6% | 112.85M▲ 0.8% | 109.16M▼ 3.3% | 148.21M▲ 35.8% |
NOI Margin % | 93.85% | 93.01% | 90.76% | 88.38% | 86.63% | 81.64% | 80.07% | 78.87% | 100% |
Operating Expenses | 18.61M | 27.23M | 14.25M | 82.65M | 63.33M | 73.27M | 74.99M | 76.48M | 148.21M |
G&A Expenses | 8.61M | 9.96M | 14.25M | 29.96M | 16.45M | 16.55M | 16.85M | 21.12M | 20M |
EBITDA | 30.34M | 53.58M | 73.7M | 53M | 84.3M | 96.37M | 96.87M | 88.76M | 77.68M |
EBITDA Margin % | 100.4% | 100.72% | 104.21% | 56.67% | 72.79% | 70.26% | 68.74% | 64.13% | 52.41% |
Depreciation & Amortization | 23M | 31.33M | 23.76M | 36.82M | 47.31M | 57.66M | 59.01M | 56.08M | 58.04M |
D&A / Revenue % | 76.09% | 58.9% | 33.6% | 39.37% | 40.85% | 42.04% | 41.87% | 40.52% | 39.16% |
Operating Income | 7.35M▲ 0% | 22.24M▲ 202.7% | 49.94M▲ 124.5% | 0▼ 100.0% | 36.99M▲ 0% | 38.71M▲ 4.7% | 37.86M▼ 2.2% | 32.68M▼ 13.7% | 0▼ 100.0% |
Operating Margin % | 24.31% | 41.82% | 70.61% | 0% | 31.94% | 28.22% | 26.87% | 23.61% | 0% |
Interest Expense | 7.43M | 14.97M | 17.47M | 18.68M | 19.7M | 25.23M | 30.89M | 28.69M | 31.75M |
Interest Coverage | 0.99x | 1.97x | 1.55x | 0.87x | 1.93x | 1.79x | 1.70x | 1.23x | 0.62x |
Non-Operating Income | 2.52M | -7.29M | 22.88M | -16.18M | -1.05M | -6.51M | -14.76M | -2.7M | -19.64M |
Pretax Income | -87K▲ 0% | 14.56M▲ 16836.8% | 9.59M▼ 34.2% | -2.5M▼ 126.1% | 18.34M▲ 834.0% | 20M▲ 9.0% | 21.73M▲ 8.7% | 6.69M▼ 69.2% | -12.12M▼ 281.1% |
Pretax Margin % | -0.29% | 27.37% | 13.56% | -2.67% | 15.84% | 14.58% | 15.42% | 4.83% | -8.17% |
Income Tax | -49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 56.32% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -38K▲ 0% | 13.49M▲ 35600.0% | 9.23M▼ 31.5% | -1.93M▼ 120.8% | 17.62M▲ 1015.4% | 19.14M▲ 8.6% | 20.61M▲ 7.7% | 6.63M▼ 67.8% | -12.12M▼ 282.7% |
Net Margin % | -0.13% | 25.36% | 13.06% | -2.06% | 15.22% | 13.96% | 14.63% | 4.79% | -8.17% |
Net Income Growth % | 99.4% | 35600% | -31.55% | -120.85% | 1015.43% | 8.63% | 7.68% | -67.82% | -282.66% |
Funds From Operations (FFO) | 22.96M▲ 0% | 44.82M▲ 95.2% | 32.99M▼ 26.4% | 34.89M▲ 5.8% | 64.93M▲ 86.1% | 76.8M▲ 18.3% | 79.62M▲ 3.7% | 62.72M▼ 21.2% | 45.93M▼ 26.8% |
FFO Margin % | 75.96% | 84.26% | 46.65% | 37.31% | 56.07% | 55.99% | 56.5% | 45.31% | 30.99% |
FFO Growth % | 463.84% | 95.23% | -26.38% | 5.75% | 86.08% | 18.29% | 3.67% | -21.23% | -26.77% |
FFO per Share | 29.26 | 51.00 | 24.36 | 18.86 | 26.77 | 29.33 | 30.37 | 23.78 | 3.43 |
FFO Payout Ratio % | 66.34% | 42.31% | 88.41% | 114.48% | 80.86% | 76.06% | 74.13% | 95.46% | 113.89% |
EPS (Diluted) | -0.05▲ 0% | 15.25▲ 32205.3% | -6.00▼ 139.3% | -11.25▼ 87.5% | -0.85▲ 92.4% | 1.02▲ 220.0% | 5.75▲ 463.7% | 0.31▼ 94.6% | -0.91▼ 393.5% |
EPS Growth % | 99.72% | 32205.26% | -139.34% | -87.5% | 92.44% | 220% | 463.73% | -94.61% | -393.55% |
EPS (Basic) | -0.05 | 15.25 | -6.00 | -11.25 | 0.97 | 1.02 | 5.75 | 0.31 | -0.91 |
Diluted Shares Outstanding | 784.68K | 878.84K | 1.35M | 1.85M | 2.43M | 2.62M | 2.62M | 2.64M | 13.38M |
GMRE Balance Sheet
Global Medical REIT Inc. (GMRE) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Total Assets | 474.57M | 636.1M | 884.93M | 1.1B | 1.26B | 1.39B | 1.27B | 1.26B | 1.24B |
Asset Growth % | 108.77% | 34.04% | 39.12% | 24.41% | 14.77% | 10.27% | -9.01% | -0.88% | -1.12% |
Real Estate & Other Assets | 7.2M | 589.99M | 18.19M | 21.98M | 1.14B | 1.26B | 1.17B | 1.17B | 0 |
PP&E (Net) | 426.26M | 139K | 792.98M | 978.71M | 3.81M | 5.03M | 10.97M | 7.27M | 0 |
Investment Securities | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 1000K | 0 |
Total Current Assets | 9.46M | 9.68M | 32.3M | 42.05M | 24.95M | 30.53M | 14.35M | 17.35M | 16.31M |
Cash & Equivalents | 5.11M | 3.63M | 2.77M | 5.51M | 7.21M | 4.02M | 1.28M | 6.82M | 9.08M |
Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
Other Current Assets | 3.64M | 2.96M | 10.37M | 10.75M | 11.5M | 18.27M | 6.12M | 2.84M | 0 |
Intangible Assets | 31.65M | 36.29M | 41.46M | 52.27M | 87.94M | 91.31M | 65.97M | 54.07M | 144.57M |
Total Liabilities | 215.56M | 336.35M | 424.58M | 643.15M | 625.91M | 744.2M | 661.89M | 700.57M | 712.4M |
Total Debt | 203.44M | 315.01M | 395.06M | 607.62M | 579.86M | 704.65M | 624.19M | 653.59M | 0 |
Net Debt | 198.34M | 311.38M | 392.3M | 602.11M | 572.64M | 700.64M | 622.91M | 646.78M | -9.08M |
Long-Term Debt | 200.69M | 315.01M | 386.17M | 586.58M | 57.16M | 57.67M | 25.9M | 14.4M | 0 |
Short-Term Borrowings | 0 | 276.35M | 6.49M | 18.09M | 514.57M | 636.45M | 585.33M | 631.73M | 0 |
Capital Lease Obligations | 1.29M | 2.03M | 2.4M | 2.96M | 8.13M | 10.54M | 12.96M | 7.46M | 0 |
Total Current Liabilities | 173.59M | 288.03M | 24.84M | 37.84M | 540.58M | 670.53M | 619.34M | 671.45M | 0 |
Accounts Payable | 2.02M | 3.66M | 5.07M | 7.28M | 10.34M | 13.82M | 12.78M | 16.47M | 0 |
Deferred Revenue | 212.81M | 336.35M | 0 | 0 | 0 | 4.44M | 5.09M | 6.73M | 0 |
Other Liabilities | 3.16M | 5.18M | 11.16M | 15.78M | 20.04M | 5.46M | 3.69M | 7.26M | 712.4M |
Total Equity | 259.01M▲ 0% | 299.75M▲ 15.7% | 460.35M▲ 53.6% | 457.76M▼ 0.6% | 637.58M▲ 39.3% | 649.07M▲ 1.8% | 605.81M▼ 6.7% | 555.92M▼ 8.2% | 530.07M▼ 4.7% |
Equity Growth % | 29.5% | 15.73% | 53.58% | -0.56% | 39.28% | 1.8% | -6.66% | -8.24% | -4.65% |
Shareholders Equity | 246.34M | 269.3M | 430.27M | 444.81M | 622.78M | 632.98M | 583.58M | 534.13M | 509.77M |
Minority Interest | 12.68M | 30.45M | 30.08M | 12.96M | 14.79M | 16.08M | 22.23M | 21.79M | 20.3M |
Common Stock | 22K | 26K | 44K | 49K | 65K | 66K | 66K | 67K | 13K |
Additional Paid-in Capital | 205.79M | 243.04M | 433.33M | 504.79M | 711.41M | 721.99M | 722.42M | 734.22M | 0 |
Retained Earnings | -34.43M | -45.01M | -71.39M | -116.77M | -157.02M | -198.71M | -238.98M | -293.74M | -349.96M |
Preferred Stock | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 124.11M |
Return on Assets (ROA) | -0.01% | 2.43% | 1.21% | -0.19% | 1.49% | 1.44% | 1.55% | 0.53% | -0.97% |
Return on Equity (ROE) | -0.02% | 4.83% | 2.43% | -0.42% | 3.22% | 2.98% | 3.29% | 1.14% | -2.23% |
Debt / Assets | 42.87% | 49.52% | 44.64% | 55.19% | 45.89% | 50.58% | 49.24% | 52.02% | - |
Debt / Equity | 0.79x | 1.05x | 0.86x | 1.33x | 0.91x | 1.09x | 1.03x | 1.18x | - |
Net Debt / EBITDA | 6.54x | 5.81x | 5.32x | 11.36x | 6.79x | 7.27x | 6.43x | 7.29x | -0.12x |
Book Value per Share | 330.09 | 341.07 | 339.84 | 247.41 | 262.85 | 247.88 | 231.05 | 210.78 | 39.62 |
GMRE Cash Flow Statement
Global Medical REIT Inc. (GMRE) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 11.6M | 24.83M | 36.43M | 34.52M | 68.97M | 76.54M | 68.44M | 70.05M | 73.61M |
Operating CF Growth % | 526.08% | 114.03% | 46.68% | -5.24% | 99.79% | 10.98% | -10.58% | 2.35% | 5.09% |
Operating CF / Revenue % | 38.39% | 46.69% | 51.5% | 36.91% | 59.55% | 55.8% | 48.56% | 50.61% | 49.67% |
Net Income | -87K | 14.56M | 9.59M | -2.5M | 18.34M | 20M | 20.61M | 6.63M | -6.88M |
Depreciation & Amortization | 10.13M | 17.96M | 25.52M | 36.82M | 47.31M | 57.66M | 59.01M | 56.08M | 58.04M |
Stock-Based Compensation | 1.8M | 2.67M | 3.34M | 5.32M | 5.81M | 4.68M | 4.24M | 5.1M | 4.5M |
Other Non-Cash Items | 1.48M | 1.75M | 1.76M | 1.56M | 1.33M | -4.06M | -9.73M | 1.01M | 17.95M |
Working Capital Changes | -1.71M | -4.43M | -3.77M | -7.65M | -3.82M | -1.74M | -5.69M | 1.21M | 0 |
Cash from Investing | -252.65M | -151.62M | -258.2M | -223.67M | -194.66M | -137.25M | 67.62M | -45.94M | -60.4M |
Acquisitions (Net) | 0 | 0 | 0 | -5.09M | 0 | 0 | 0 | 0 | 0 |
Purchase of Investments | -426K | -373K | 0 | -1.54M | -2.78M | 0 | 0 | 0 | 0 |
Sale of Investments | 21K | 23.95M | 0 | 208K | 0 | 0 | 0 | 57.62M | 21.47M |
Other Investing | -433K | 5.26M | -3.21M | 1.54M | 366K | 13.68M | 67.62M | -103.56M | -81.87M |
Cash from Financing | 226.49M | 124.51M | 224.11M | 192.72M | 127.7M | 62.41M | -143.79M | -21.89M | -10.26M |
Dividends Paid | -15.98M | -24.79M | -34.99M | -45.77M | -58.32M | -64.24M | -64.85M | -65.69M | -52.31M |
Common Dividends | -15.23M | -18.96M | -29.17M | -39.94M | -52.5M | -58.42M | -59.02M | -59.87M | 0 |
Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 0 |
Share Repurchases | 0 | -263K | 0 | 0 | 0 | 0 | 0 | 0 | -6M |
Other Financing | -3.06M | -3.1M | -1.33M | -2.83M | -8.89M | -5.19M | 7.15M | 252K | 42.05M |
Net Change in Cash | -14.56M▲ 0% | -2.27M▲ 84.4% | 2.34M▲ 203.1% | 3.57M▲ 52.3% | 2.01M▼ 43.8% | 1.7M▼ 15.5% | -7.73M▼ 555.8% | 2.22M▲ 128.7% | 2.95M▲ 32.9% |
Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash at Beginning | 19.67M | 7.11M | 4.84M | 7.18M | 10.75M | 12.76M | 14.46M | 6.72M | 8.94M |
Cash at End | 5.11M | 4.84M | 7.18M | 10.75M | 12.76M | 14.46M | 6.72M | 8.94M | 11.89M |
Free Cash Flow | -240.62M▲ 0% | -156M▲ 35.2% | -220.38M▼ 41.3% | -184.27M▲ 16.4% | -132.69M▲ 28.0% | -79.66M▲ 40.0% | 58.39M▲ 173.3% | -25.07M▼ 142.9% | 73.61M▲ 393.6% |
FCF Growth % | -57.08% | 35.17% | -41.27% | 16.39% | 27.99% | 39.97% | 173.3% | -142.94% | 393.58% |
FCF / Revenue % | -796.14% | -293.28% | -311.6% | -197.04% | -114.58% | -58.08% | 41.43% | -18.12% | 49.67% |
GMRE Key Ratios
Global Medical REIT Inc. (GMRE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
FFO per Share | 10.94 | 29.26 | 51 | 24.36 | 18.86 | 26.77 | 29.33 | 30.37 | 23.78 | 3.43 |
FFO Payout Ratio | 95.24% | 66.34% | 42.31% | 88.41% | 114.48% | 80.86% | 76.06% | 74.13% | 95.46% | 113.89% |
NOI Margin | 82.25% | 93.85% | 93.01% | 90.76% | 88.38% | 86.63% | 81.64% | 80.07% | 78.87% | 100% |
Net Debt / EBITDA | 5.71x | 6.54x | 5.81x | 5.32x | 11.36x | 6.79x | 7.27x | 6.43x | 7.29x | -0.12x |
Debt / Assets | 29.27% | 42.87% | 49.52% | 44.64% | 55.19% | 45.89% | 50.58% | 49.24% | 52.02% | - |
Interest Coverage | -0.53x | 0.99x | 1.97x | 1.55x | 0.87x | 1.93x | 1.79x | 1.70x | 1.23x | 0.62x |
Book Value / Share | 537.56 | 330.09 | 341.07 | 339.84 | 247.41 | 262.85 | 247.88 | 231.05 | 210.78 | 39.62 |
Revenue Growth | 291.89% | 274.07% | 76% | 32.96% | 32.23% | 23.83% | 18.45% | 2.75% | -1.79% | 7.08% |
Related:GMRE Dividend History·GMRE Revenue History·GMRE Price History·GMRE P/E History·GMRE Financial Ratios·GMRE Institutional Holders
GMRE Frequently Asked Questions
Global Medical REIT Inc. (GMRE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Global Medical REIT Inc. (GMRE) reported $148.2M in revenue for fiscal year 2025.
Global Medical REIT Inc. (GMRE) grew revenue by 7.1% over the past year. This is steady growth.
Global Medical REIT Inc. (GMRE) reported a net loss of $12.1M for fiscal year 2025.
Dividend & Returns
Yes, Global Medical REIT Inc. (GMRE) pays a dividend with a yield of 63.51%. This makes it attractive for income-focused investors.
Global Medical REIT Inc. (GMRE) has a return on equity (ROE) of -2.2%. Negative ROE indicates the company is unprofitable.
Industry Metrics
Global Medical REIT Inc. (GMRE) generated Funds From Operations (FFO) of $47.7M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Global Medical REIT Inc. (GMRE) offers a 63.51% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.